Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-01

AUTHORS

Shohei Koyama, Naoto Koike, Shinya Adachi

ABSTRACT

We investigated the presence and functional status of surface expression of the Fas receptor (FasR) and its ligand (FasL) in tumor and tumor-infiltrating lymphocytes (TIL) in gastric carcinoma (n=36) from the primary locus, metastatic gastric carcinoma (n=30) from malignant ascites, and benign gastric mucosa (n=30) for the control. The quantitative analysis was based on the percentage of positive cells by a flow cytometry. The results showed that the membrane-bound FasL molecule was constitutively expressed in primary and metastatic gastric carcinomas as well as normal gastric epithelium in nearly all the patients. In particular, metastatic carcinoma proved to aberrantly express the FasL molecule. On the other hand, FasR expression ranged from minimal or absent in primary and metastatic gastric carcinomas, suggesting that the carcinoma might be rendered less sensitive toward FasR-induced killing. Apoptotic tumor cells detected by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick and labeling (TUNEL) were barely identified in primary and metastatic carcinomas. In the analysis of TIL, the expression of FasR and FasL, and apoptotic TIL could not usually be observed in primary gastric carcinoma. In metastatic carcinoma, however, there was significant overexpression of FasR and FasL in immune TIL associated with a higher frequency of apoptotic cell death detected by TUNEL. The results suggest that metastatic carcinoma expressing FasL, but not FasL+ primary carcinoma, might evade the immune attack by apoptotic depletion of activated TIL through the FasR/FasL systems. These results provide the direct and quantitative evidence of FasR counterattacks and/or paracrine fratricides as a mechanism of tumor-immune escape in vivo in human cancer. More... »

PAGES

20-26

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s004320000181

DOI

http://dx.doi.org/10.1007/s004320000181

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052848144

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11206267


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ascites", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Membrane", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Separation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epithelium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fas Ligand Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Situ Nick-End Labeling", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocytes, Tumor-Infiltrating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Glycoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stomach Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "fas Receptor", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, 305-8575 Japan e-mail: s-koyama@md.tsukuba.ac.jp Tel.: +81-298-533210; Fax: +81-298-533039, JP", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, 305-8575 Japan e-mail: s-koyama@md.tsukuba.ac.jp Tel.: +81-298-533210; Fax: +81-298-533039, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koyama", 
        "givenName": "Shohei", 
        "id": "sg:person.0657656236.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657656236.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koike", 
        "givenName": "Naoto", 
        "id": "sg:person.01330372147.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330372147.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Adachi", 
        "givenName": "Shinya", 
        "id": "sg:person.0743060207.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743060207.94"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2001-01", 
    "datePublishedReg": "2001-01-01", 
    "description": "Abstract We investigated the presence and functional status of surface expression of the Fas receptor (FasR) and its ligand (FasL) in tumor and tumor-infiltrating lymphocytes (TIL) in gastric carcinoma (n=36) from the primary locus, metastatic gastric carcinoma (n=30) from malignant ascites, and benign gastric mucosa (n=30) for the control. The quantitative analysis was based on the percentage of positive cells by a flow cytometry. The results showed that the membrane-bound FasL molecule was constitutively expressed in primary and metastatic gastric carcinomas as well as normal gastric epithelium in nearly all the patients. In particular, metastatic carcinoma proved to aberrantly express the FasL molecule. On the other hand, FasR expression ranged from minimal or absent in primary and metastatic gastric carcinomas, suggesting that the carcinoma might be rendered less sensitive toward FasR-induced killing. Apoptotic tumor cells detected by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick and labeling (TUNEL) were barely identified in primary and metastatic carcinomas. In the analysis of TIL, the expression of FasR and FasL, and apoptotic TIL could not usually be observed in primary gastric carcinoma. In metastatic carcinoma, however, there was significant overexpression of FasR and FasL in immune TIL associated with a higher frequency of apoptotic cell death detected by TUNEL. The results suggest that metastatic carcinoma expressing FasL, but not FasL+ primary carcinoma, might evade the immune attack by apoptotic depletion of activated TIL through the FasR/FasL systems. These results provide the direct and quantitative evidence of FasR counterattacks and/or paracrine fratricides as a mechanism of tumor-immune escape in vivo in human cancer.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s004320000181", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "127"
      }
    ], 
    "keywords": [
      "tumor-infiltrating lymphocytes", 
      "metastatic gastric carcinoma", 
      "metastatic carcinoma", 
      "gastric carcinoma", 
      "analysis of TIL", 
      "apoptotic tumor-infiltrating lymphocytes", 
      "FasL molecules", 
      "tumor immune escape", 
      "expression of FasR", 
      "benign gastric mucosa", 
      "normal gastric epithelium", 
      "apoptotic tumor cells", 
      "primary gastric carcinomas", 
      "malignant ascites", 
      "primary carcinoma", 
      "functional status", 
      "immune attack", 
      "immune escape", 
      "apoptotic depletion", 
      "gastric mucosa", 
      "positive cells", 
      "carcinoma", 
      "gastric epithelium", 
      "terminal deoxynucleotidyl transferase", 
      "flow cytometry", 
      "FasR expression", 
      "significant overexpression", 
      "tumor cells", 
      "FasL system", 
      "dUTP nick", 
      "apoptotic cell death", 
      "human cancers", 
      "surface expression", 
      "FasL", 
      "Fas receptor", 
      "deoxynucleotidyl transferase", 
      "lymphocytes", 
      "cell death", 
      "FasR", 
      "vivo", 
      "expression", 
      "primary locus", 
      "ascites", 
      "cells", 
      "patients", 
      "mucosa", 
      "high frequency", 
      "tumors", 
      "cancer", 
      "epithelium", 
      "receptors", 
      "cytometry", 
      "TUNEL", 
      "death", 
      "overexpression", 
      "killing", 
      "status", 
      "escape", 
      "transferase", 
      "mechanism", 
      "percentage", 
      "quantitative evidence", 
      "evidence", 
      "depletion", 
      "control", 
      "labeling", 
      "quantitative analysis", 
      "fratricide", 
      "results", 
      "nick", 
      "analysis", 
      "presence", 
      "molecules", 
      "frequency", 
      "counterattack", 
      "hand", 
      "ligands", 
      "loci", 
      "attacks", 
      "Abstract", 
      "system"
    ], 
    "name": "Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma", 
    "pagination": "20-26", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052848144"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s004320000181"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11206267"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s004320000181", 
      "https://app.dimensions.ai/details/publication/pub.1052848144"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_344.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s004320000181"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s004320000181'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s004320000181'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s004320000181'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s004320000181'


 

This table displays all metadata directly associated to this object as RDF triples.

234 TRIPLES      20 PREDICATES      126 URIs      118 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s004320000181 schema:about N360fe4a82795440d8df0b892bad5ef0c
2 N36828a3cc7a642d39515fb5573214440
3 N5040b937b8c24eb295137bd5be782140
4 N6030bd2066e14e158ca5845e4a0412cc
5 N6ae47c7f5ec5498c906cd5a921c72ea2
6 N83027b6140f241edac87990f3496d2c6
7 N8b6a961e50644163b0010a22bc503b13
8 Na1e61e62b9f14eb7879c4f3af9196eb7
9 Nab923fe032d146828f9e73f1764542d1
10 Nad18255e65b24f02a9cb62b6b3812ae0
11 Nb052fd2f9c3a49d8a985cf8a28800128
12 Nbc5b53f59c1f4b638634784f481abf9b
13 Nc19272eba3664c8caccdf2973c00fb97
14 Nc4128f0fb44045ef9281773c88f1c117
15 Nd6e31cb713894e7d8d40e5af92032272
16 Nf566d2e13f6f451daa017549f549d6f8
17 Nf77d9fcf83434639a5aa2610d3434c8d
18 Nf8bb968674db40acb4bef2ed8b7a4654
19 Nfaea5c8f0cd649c7a9b3c6e6aabb7c44
20 anzsrc-for:11
21 anzsrc-for:1107
22 schema:author N81c5a754bcdb4a61a2a52d9292925c74
23 schema:datePublished 2001-01
24 schema:datePublishedReg 2001-01-01
25 schema:description Abstract We investigated the presence and functional status of surface expression of the Fas receptor (FasR) and its ligand (FasL) in tumor and tumor-infiltrating lymphocytes (TIL) in gastric carcinoma (n=36) from the primary locus, metastatic gastric carcinoma (n=30) from malignant ascites, and benign gastric mucosa (n=30) for the control. The quantitative analysis was based on the percentage of positive cells by a flow cytometry. The results showed that the membrane-bound FasL molecule was constitutively expressed in primary and metastatic gastric carcinomas as well as normal gastric epithelium in nearly all the patients. In particular, metastatic carcinoma proved to aberrantly express the FasL molecule. On the other hand, FasR expression ranged from minimal or absent in primary and metastatic gastric carcinomas, suggesting that the carcinoma might be rendered less sensitive toward FasR-induced killing. Apoptotic tumor cells detected by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick and labeling (TUNEL) were barely identified in primary and metastatic carcinomas. In the analysis of TIL, the expression of FasR and FasL, and apoptotic TIL could not usually be observed in primary gastric carcinoma. In metastatic carcinoma, however, there was significant overexpression of FasR and FasL in immune TIL associated with a higher frequency of apoptotic cell death detected by TUNEL. The results suggest that metastatic carcinoma expressing FasL, but not FasL+ primary carcinoma, might evade the immune attack by apoptotic depletion of activated TIL through the FasR/FasL systems. These results provide the direct and quantitative evidence of FasR counterattacks and/or paracrine fratricides as a mechanism of tumor-immune escape in vivo in human cancer.
26 schema:genre article
27 schema:isAccessibleForFree false
28 schema:isPartOf Na8e83aec4bd34ab7aeeb9be7a87846ce
29 Nfef90504922e4e38bccb86fb25598d48
30 sg:journal.1313647
31 schema:keywords Abstract
32 Fas receptor
33 FasL
34 FasL molecules
35 FasL system
36 FasR
37 FasR expression
38 TUNEL
39 analysis
40 analysis of TIL
41 apoptotic cell death
42 apoptotic depletion
43 apoptotic tumor cells
44 apoptotic tumor-infiltrating lymphocytes
45 ascites
46 attacks
47 benign gastric mucosa
48 cancer
49 carcinoma
50 cell death
51 cells
52 control
53 counterattack
54 cytometry
55 dUTP nick
56 death
57 deoxynucleotidyl transferase
58 depletion
59 epithelium
60 escape
61 evidence
62 expression
63 expression of FasR
64 flow cytometry
65 fratricide
66 frequency
67 functional status
68 gastric carcinoma
69 gastric epithelium
70 gastric mucosa
71 hand
72 high frequency
73 human cancers
74 immune attack
75 immune escape
76 killing
77 labeling
78 ligands
79 loci
80 lymphocytes
81 malignant ascites
82 mechanism
83 metastatic carcinoma
84 metastatic gastric carcinoma
85 molecules
86 mucosa
87 nick
88 normal gastric epithelium
89 overexpression
90 patients
91 percentage
92 positive cells
93 presence
94 primary carcinoma
95 primary gastric carcinomas
96 primary locus
97 quantitative analysis
98 quantitative evidence
99 receptors
100 results
101 significant overexpression
102 status
103 surface expression
104 system
105 terminal deoxynucleotidyl transferase
106 transferase
107 tumor cells
108 tumor immune escape
109 tumor-infiltrating lymphocytes
110 tumors
111 vivo
112 schema:name Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma
113 schema:pagination 20-26
114 schema:productId N6a6ea920594e4baa818ed2bbe7727d4a
115 N87c7548186214e85908c01c152d7cd40
116 Nbb8dc6fab6d0473bb9bd988ed2c9ee08
117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052848144
118 https://doi.org/10.1007/s004320000181
119 schema:sdDatePublished 2022-12-01T06:23
120 schema:sdLicense https://scigraph.springernature.com/explorer/license/
121 schema:sdPublisher Nc979484648f6481fba94d297e1826854
122 schema:url https://doi.org/10.1007/s004320000181
123 sgo:license sg:explorer/license/
124 sgo:sdDataset articles
125 rdf:type schema:ScholarlyArticle
126 N360fe4a82795440d8df0b892bad5ef0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Stomach Neoplasms
128 rdf:type schema:DefinedTerm
129 N36828a3cc7a642d39515fb5573214440 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Adult
131 rdf:type schema:DefinedTerm
132 N4df99b4e39f540a78843b57f86bb1d78 rdf:first sg:person.0743060207.94
133 rdf:rest rdf:nil
134 N5040b937b8c24eb295137bd5be782140 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Apoptosis
136 rdf:type schema:DefinedTerm
137 N6030bd2066e14e158ca5845e4a0412cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name In Situ Nick-End Labeling
139 rdf:type schema:DefinedTerm
140 N6a6ea920594e4baa818ed2bbe7727d4a schema:name dimensions_id
141 schema:value pub.1052848144
142 rdf:type schema:PropertyValue
143 N6ae47c7f5ec5498c906cd5a921c72ea2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Cell Membrane
145 rdf:type schema:DefinedTerm
146 N81c5a754bcdb4a61a2a52d9292925c74 rdf:first sg:person.0657656236.00
147 rdf:rest N9b73c67f6a684e908136f17103e74726
148 N83027b6140f241edac87990f3496d2c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Epithelium
150 rdf:type schema:DefinedTerm
151 N87c7548186214e85908c01c152d7cd40 schema:name doi
152 schema:value 10.1007/s004320000181
153 rdf:type schema:PropertyValue
154 N8b6a961e50644163b0010a22bc503b13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Middle Aged
156 rdf:type schema:DefinedTerm
157 N9b73c67f6a684e908136f17103e74726 rdf:first sg:person.01330372147.74
158 rdf:rest N4df99b4e39f540a78843b57f86bb1d78
159 Na1e61e62b9f14eb7879c4f3af9196eb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Carcinoma
161 rdf:type schema:DefinedTerm
162 Na8e83aec4bd34ab7aeeb9be7a87846ce schema:issueNumber 1
163 rdf:type schema:PublicationIssue
164 Nab923fe032d146828f9e73f1764542d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Fas Ligand Protein
166 rdf:type schema:DefinedTerm
167 Nad18255e65b24f02a9cb62b6b3812ae0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Antibodies, Monoclonal
169 rdf:type schema:DefinedTerm
170 Nb052fd2f9c3a49d8a985cf8a28800128 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Aged, 80 and over
172 rdf:type schema:DefinedTerm
173 Nbb8dc6fab6d0473bb9bd988ed2c9ee08 schema:name pubmed_id
174 schema:value 11206267
175 rdf:type schema:PropertyValue
176 Nbc5b53f59c1f4b638634784f481abf9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Ascites
178 rdf:type schema:DefinedTerm
179 Nc19272eba3664c8caccdf2973c00fb97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Aged
181 rdf:type schema:DefinedTerm
182 Nc4128f0fb44045ef9281773c88f1c117 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Humans
184 rdf:type schema:DefinedTerm
185 Nc979484648f6481fba94d297e1826854 schema:name Springer Nature - SN SciGraph project
186 rdf:type schema:Organization
187 Nd6e31cb713894e7d8d40e5af92032272 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Cell Separation
189 rdf:type schema:DefinedTerm
190 Nf566d2e13f6f451daa017549f549d6f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Flow Cytometry
192 rdf:type schema:DefinedTerm
193 Nf77d9fcf83434639a5aa2610d3434c8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Lymphocytes, Tumor-Infiltrating
195 rdf:type schema:DefinedTerm
196 Nf8bb968674db40acb4bef2ed8b7a4654 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name fas Receptor
198 rdf:type schema:DefinedTerm
199 Nfaea5c8f0cd649c7a9b3c6e6aabb7c44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Membrane Glycoproteins
201 rdf:type schema:DefinedTerm
202 Nfef90504922e4e38bccb86fb25598d48 schema:volumeNumber 127
203 rdf:type schema:PublicationVolume
204 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
205 schema:name Medical and Health Sciences
206 rdf:type schema:DefinedTerm
207 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
208 schema:name Immunology
209 rdf:type schema:DefinedTerm
210 sg:journal.1313647 schema:issn 0171-5216
211 1432-1335
212 schema:name Journal of Cancer Research and Clinical Oncology
213 schema:publisher Springer Nature
214 rdf:type schema:Periodical
215 sg:person.01330372147.74 schema:affiliation grid-institutes:grid.20515.33
216 schema:familyName Koike
217 schema:givenName Naoto
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330372147.74
219 rdf:type schema:Person
220 sg:person.0657656236.00 schema:affiliation grid-institutes:grid.20515.33
221 schema:familyName Koyama
222 schema:givenName Shohei
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657656236.00
224 rdf:type schema:Person
225 sg:person.0743060207.94 schema:affiliation grid-institutes:grid.20515.33
226 schema:familyName Adachi
227 schema:givenName Shinya
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743060207.94
229 rdf:type schema:Person
230 grid-institutes:grid.20515.33 schema:alternateName Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, 305-8575 Japan e-mail: s-koyama@md.tsukuba.ac.jp Tel.: +81-298-533210; Fax: +81-298-533039, JP
231 Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP
232 schema:name Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, 305-8575 Japan e-mail: s-koyama@md.tsukuba.ac.jp Tel.: +81-298-533210; Fax: +81-298-533039, JP
233 Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP
234 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...